Literature DB >> 27038509

Thermostabilization of the Human Endothelin Type B Receptor.

Akiko Okuta1, Kazutoshi Tani2, Shoko Nishimura2, Yoshinori Fujiyoshi3, Tomoko Doi4.   

Abstract

The peptide hormone endothelin, produced by the vascular endothelium, is involved in several physiological functions, including maintenance of vascular tone and humoral homeostasis. Endothelin transmits signals through the endothelin receptor, a G-protein-coupled receptor. Structural studies of the endothelin type B receptor (ETBR) have been unsuccessful due to its structural flexibility and instability in detergent-solubilized solution. To overcome these problems, we explored thermostabilization of human ETBR by establishing an ETBR expression system in Escherichia coli, followed by systematic alanine scanning mutagenesis. Among 297 point mutations, 11 thermostabilizing residues were selected and further mutated to other amino acids. The thermostability indices of these residues, represented by the ratios of endothelin-1 (ET-1) binding activities with or without heat treatment at 27°C for 30min in a ligand-free form, were compared. The ligand affinity and apparent melting temperature (Tm) of the five most thermostable mutants, R124Y, D154A, K270A, S342A, and I381A, were then examined. The apparent Tm of three single mutants, R124Y, D154A, and K270A, was approximately 7°C higher than that of the wild type. The apparent Tm value of a combination of the five residues, named the Y5 ETBR mutant, was 17°C higher than that of the wild type. The Y5 ETBR mutant exhibited an affinity for ET-1 and activated Gq similar to the wild type. Further investigation of the pharmacological properties affected by combinatorial mutations of ET-1, ET-3, TxET-1, and K8794 suggested that Y5 ETBR is highly suitable for representing a ligand-free form of ETBR and is potentially applicable for studying an ET-1-bound form.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  G-protein-coupled receptor; alanine scanning mutagenesis; homology model; thermostabilization

Mesh:

Substances:

Year:  2016        PMID: 27038509     DOI: 10.1016/j.jmb.2016.03.024

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  6 in total

1.  X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog.

Authors:  Wataru Shihoya; Tomohiro Nishizawa; Keitaro Yamashita; Asuka Inoue; Kunio Hirata; Francois Marie Ngako Kadji; Akiko Okuta; Kazutoshi Tani; Junken Aoki; Yoshinori Fujiyoshi; Tomoko Doi; Osamu Nureki
Journal:  Nat Struct Mol Biol       Date:  2017-08-14       Impact factor: 15.369

2.  Activation mechanism of endothelin ETB receptor by endothelin-1.

Authors:  Wataru Shihoya; Tomohiro Nishizawa; Akiko Okuta; Kazutoshi Tani; Naoshi Dohmae; Yoshinori Fujiyoshi; Osamu Nureki; Tomoko Doi
Journal:  Nature       Date:  2016-09-05       Impact factor: 49.962

3.  Crystal structures of human ETB receptor provide mechanistic insight into receptor activation and partial activation.

Authors:  Wataru Shihoya; Tamaki Izume; Asuka Inoue; Keitaro Yamashita; Francois Marie Ngako Kadji; Kunio Hirata; Junken Aoki; Tomohiro Nishizawa; Osamu Nureki
Journal:  Nat Commun       Date:  2018-11-09       Impact factor: 14.919

4.  Computational design of thermostabilizing point mutations for G protein-coupled receptors.

Authors:  Petr Popov; Yao Peng; Ling Shen; Raymond C Stevens; Vadim Cherezov; Zhi-Jie Liu; Vsevolod Katritch
Journal:  Elife       Date:  2018-06-21       Impact factor: 8.140

5.  Crystal structure of human endothelin ETB receptor in complex with peptide inverse agonist IRL2500.

Authors:  Chisae Nagiri; Wataru Shihoya; Asuka Inoue; Francois Marie Ngako Kadji; Junken Aoki; Osamu Nureki
Journal:  Commun Biol       Date:  2019-06-21

6.  Transfer mechanism of cell-free synthesized membrane proteins into mammalian cells.

Authors:  Simon Umbach; Roman Levin; Sebastian Neumann; Torsten Steinmetzer; Volker Dötsch; Frank Bernhard
Journal:  Front Bioeng Biotechnol       Date:  2022-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.